XRCC4 and glioblastoma: In this study, we develop a murine GBM model in which knockout of both p53 and XRCC4 is specifically targeted in neural stem/progenitors in the developing brain, and use this model to investigate the impact of NHEJ deficiency on p53-mediated gliomagenesis.